Telegram RegisterThe public register of Telegram
Telegram profile photo for نکات دارویی و بالینی | beSTudent

Channel

نکات دارویی و بالینی | beSTudent

@beSTudent_Rx

On this record: Growth · Engagement · Reactions · Posts · Polls · Citations · Cite this entry

741subscribers

+2 since we began measuring on 10 September 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1003945404445
TypeChannel
Username@beSTudent_Rx
CreatedBetween 1 April 2026 and 30 August 2026 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded10 September 2026
Last confirmed live12 September 2026
Measurements held3
Confirmed unchanged1 time, most recently 12 September 2026
On Telegramt.me/beSTudent_Rx

Growth

73974174010 September 2026 — 739 subscribers10 September 2026 — 739 subscribers12 September 2026 — 741 subscribers10 September 202612 September 2026
3 measurements spanning 2 days, net +2. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 739–741 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
12 Sept 2026, 18:40741+2
10 Sept 2026, 21:22739no change
10 Sept 2026, 20:47739first reading

Engagement

20 posts held, back to 30 August 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

ERR · 30 days
46.1%
avg views ÷ 741 subscribers
Avg views / post
341
20 posts measured
Reaction rate
1.44%
reactions ÷ views · ER floor
Posts in window
20
of 20 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate. It is computed over the 14 of 20 measured posts that carry a reaction reading, and over those same posts' views.

What these figures were computed from
WindowRolling 30 days · latest post in window 10 September 2026
Posts held20 (30 August 202610 September 2026)
Views total6,825
Reactions total78
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken10 Sept 2026, 21:22 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

78 reactions across 14 posts, in 4 distinct kinds. The most used accounts for 59.0% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
4659.0%
👍1823.1%
🔥1316.7%
🙏11.28%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 14 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 78 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 30 August 2026 to 10 September 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

10 Sept 2026, 07:02 UTC242 views5 reactionsread 10 September 2026

#دارودرمانی 7️⃣6️⃣ 📌انسولین Degludec با برند Tresiba®️ 🎇انسولین جدید در بازار ایران ▪️دگلودک انسولینی طولانی‌اثر است که به عنوان جزء بازال انسولین تراپی در کنترل DM تیپ ۱ و ۲ کاربرد دارد. 💉پن دگلودک حاوی 100 واحد در میلی‌لیتر از محلول دارو است. 🕔سرعت جذب، شروع و طول اثر آن مانند سایر انسولین‌ها متاثر از محل تزریق، فعالیت بدنی، وجود یا عدم وجود لیپودیستروفی، گردش‌خون و دمای ناحیه تزریق است با این حال؛ ⬅️شروع اث

5

Signed Nazanin.Z

9 Sept 2026, 07:00 UTC161 views7 reactionsread 10 September 2026

#دارودرمانی 6️⃣6️⃣ بزرگسالان در معرض خطر بالاتر عوارض ناشی از آنفلوانزا ◼️ بزرگسالان ≥۶۵ سال ◼️ افراد باردار یا تا ۲ هفته پس از زایمان ◼️ ساکنین خانه‌های سالمندان و مراکز مراقبت طولانی‌مدت ◼️ افراد سیاه‌پوست غیرهیسپانیک، اسپانیایی‌تبار یا لاتین‌تبار، و بومیان آمریکا یا آلاسکا ◼️ افراد با شرایط پزشکی شامل: ▫️ آسم ▫️ اختلالات نورولوژیک و نورودولوپمنتال (شامل اختلالات مغز، نخاع، اعصاب محیطی و عضلات مانند فلج مغزی، صر

5🔥2

Signed Ghazaleh Farhadi

9 Sept 2026, 06:31 UTC168 views4 reactionsread 10 September 2026

امروز در مورد افراد در معرض خطر بالاتر در برابر آنفولانزا صحبت میشه

3👍1

Signed Ghazaleh Farhadi

8 Sept 2026, 07:00 UTC208 views10 reactionsread 10 September 2026

#دارودرمانی 5️⃣6️⃣ 💊ساپروپترین (Sapropterin) دسته دارویی: کوفاکتور آنزیمی مورد مصرف ساپروپترین برای کاهش سطح فنیل‌آلانین (PHE) خون در افرادی استفاده می‌شود که دچار فنیل‌کتونوری (PKU) پاسخ‌دهنده به BH4 هستند. دارو باید همراه با رژیم غذایی محدود از نظر فنیل‌آلانین مصرف شود. دوز مصرفیبزرگسالان ◽شروع: ۱۰ تا ۲۰ میلی‌گرم به ازای هر کیلوگرم، روزی یک بار، پس از حدود ۱ ماه، بر اساس سطح فنیل‌آلانین خون دوز تنظیم می‌شود.ا

🔥73

Signed Ghazaleh Farhadi

6 Sept 2026, 06:59 UTC264 views12 reactionsread 10 September 2026

#دارودرمانی 5️⃣6️⃣ 🟡 ادم محیطی ناشی از CCB ها به توزیع مجدد مایع از فضای عروقی به فضای بینابینی مربوط می‌ شود. خطر بروز ادم با CCB های دی هیدروپیریدنی (مانند آملودیپین) بیشتر از غیر دی هیدروپیریدنی ها (مانند وراپامیل و دیلتیازم) است. 🟧 ادم ناشی از DHP-CCB ها را می‌توان با هر یک از اقدامات زیر مدیریت کرد: - کاهش دوز - تعویض دارو با یک NDHP-CCB - و/یا افزودن یک عامل مسدودکننده RAS مانند ACEI و ARB ❌️ توجه: ادم ناشی

👍93

Signed Parsa Yahyaei

6 Sept 2026, 06:34 UTC256 viewsread 10 September 2026
Poll

کدام اقدام در کاهش ادم ناشی از آملودیپین موثر نیست؟

  1. کاهش دوز18%
  2. تغییر دارو به وراپامیل14%
  3. افزودن دیورتیک38%
  4. افزودن ACEI یا ARB29%

Shares as published, totalling 99%. No per-option vote count is published by Telegram, so none is shown.

Signed Parsa Yahyaei

5 Sept 2026, 07:00 UTC830 views5 reactionsread 10 September 2026

#دارودرمانی 4️⃣6️⃣ 📍ناتامایسین دسته دارویی داروی ضدقارچ چشمی دوز مصرفی ۱)کراتیت قارچی (عفونت قارچی قرنیه): یک قطره در کیسه ملتحمه چشم، هر ۱ تا ۲ ساعت یک‌بار چکانده شود. پس از ۳ تا ۴ روز، در صورت بهبود، مقدار مصرف به یک قطره، ۶ تا ۸ بار در روز کاهش داده می‌شود. طول معمول درمان ۲ تا ۳ هفته است یا تا زمانی که علائم و عفونت فعال قارچی برطرف شود. ممکن است پزشک برای اطمینان از ریشه‌کن شدن قارچ، دوز دارو را به‌تدریج و در

👍21🔥1🙏1

Signed Ghazaleh Farhadi

3 Sept 2026, 07:05 UTC792 views4 reactionsread 10 September 2026

#دارودرمانی 3️⃣6️⃣ 📌رتبه‌بندی کورتون‌های چشمی ▫️در آپتودیت گروهی با عنوان 《soft》برای کورتیکواستروئیدهای چشمی ذکر شده‌است که شامل لوتپردنول(برند لوتمکس و آلرکس)، پردنیزولون (برند پردمایلد)، فلورومتولون (برند FML) و مدریزون (برند HMS) است. ▪️داروهای این گروه با پوتنسی متوسط، ریسک IOP کمی دارند. مصرف آن‌ها معمولا ۲ تا ۴ بار در روز و حداکثر به مدت ۲ هفته توصیه میشود و مصرف بیش از ۶ هفته آنها باعث افزایش ریسک عوارض جان

4

Signed Nazanin.Z

3 Sept 2026, 07:04 UTC260 views2 reactionsread 10 September 2026
Photo

جدول کورتون‌های چشمی اپلاید

2

Signed Nazanin.Z

Showing the 12 most recent of 20 posts we hold for @beSTudent_Rx. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Polls

The 2 polls we hold for this entry, as Telegram rendered them when we read the post. A poll’s figures keep moving after that, so each one is dated.

6 Sept 2026, 06:34 UTCAnonymous Quiz92 voters

کدام اقدام در کاهش ادم ناشی از آملودیپین موثر نیست؟

  1. کاهش دوز18%
  2. تغییر دارو به وراپامیل14%
  3. افزودن دیورتیک38%
  4. افزودن ACEI یا ARB29%

Shares as published, totalling 99%. No per-option vote count is published by Telegram, so none is shown.

30 Aug 2026, 06:31 UTCAnonymous Quiz93 voters

کدام عارضه تیروئیدی با داروی آمیودارون گزارش شده است؟

  1. هایپوتیروئیدی23%
  2. هایپرتیروئیدی13%
  3. هردو62%
  4. تاثیری بر تیروئید ندارد2%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Percentages only — there are no per-option vote counts here, because Telegram publishes none. The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.

The shares need not add up to 100. Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.

Read from the 20 most recent posts we hold, published 30 August 2026 to 10 September 2026. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 12 September 2026 — this entry's latest reading, not the date you are reading this.

“نکات دارویی و بالینی | beSTudent” (@beSTudent_Rx), 741 subscribers as measured 12 September 2026. Telegram Register, tgregister.com/channel/beSTudent_Rx.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.